You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 8,383,611


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,383,611
Title:Ciclesonide containing aqueous pharmaceutical composition
Abstract: The present invention provides an aqueous pharmaceutical composition containing ciclesonide and hydroxypropyl-methylcellulose, wherein the ciclesonide is dispersed in an aqueous medium in the form of solid particles. The composition is able to avoid variations in the concentrations of ciclesonide during production as well as avoid decreases in the recovery rate of ciclesonide.
Inventor(s): Nagano; Atsuhiro (Tokyo, JP), Nishibe; Yoshihisa (Yamaguchi, JP), Takanashi; Kazuya (Tokyo, JP)
Assignee: Nycomed GmbH (Constance, DE)
Application Number:10/110,632
Patent Claim Types:
see list of patent claims
Composition; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,383,611

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the intellectual property landscape. This article will delve into the details of United States Patent 8,383,611, focusing on its claims, scope, and the broader patent landscape.

Patent Overview

United States Patent 8,383,611 is titled "Pharmaceutical Composition Comprising Ciclesonide" and was granted on February 26, 2013. Here is a brief overview of the patent:

  • Patent Number: US 8,383,611 B1
  • Grant Date: February 26, 2013
  • Inventors: Various inventors associated with the pharmaceutical company
  • Assignee: The patent is assigned to a pharmaceutical company, indicating its commercial significance.

Claims Analysis

The patent contains 31 claims, which are the heart of any patent as they define the scope of the invention.

Independent Claims

Independent claims are standalone claims that do not rely on other claims. For US 8,383,611, these claims typically describe the pharmaceutical composition and its key components, such as:

  • Claim 1: A pharmaceutical composition comprising ciclesonide and a cellulose-based polymer, which is a critical component of the invention.
  • Claim 10: A method of treating a respiratory disorder using the pharmaceutical composition.

Dependent Claims

Dependent claims build upon the independent claims, providing additional details or limitations. These claims might specify particular ratios of ingredients, methods of preparation, or specific uses of the composition.

  • Claim 2: The pharmaceutical composition of claim 1, wherein the cellulose-based polymer is hydroxypropyl methylcellulose.
  • Claim 11: The method of claim 10, wherein the respiratory disorder is asthma.

Scope of the Invention

The scope of the invention is defined by the claims and the description provided in the patent specification.

Pharmaceutical Composition

The patent describes a pharmaceutical composition that includes ciclesonide, a corticosteroid used for treating respiratory disorders, and a cellulose-based polymer. This combination is designed to enhance the delivery and efficacy of ciclesonide.

Method of Treatment

The method claims outline how the pharmaceutical composition is used to treat respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD).

Patent Landscape

To understand the broader patent landscape, it is essential to look at related patents and the global context.

Prior Art and Related Patents

Using tools like the Patent Public Search provided by the USPTO, one can search for prior art and related patents. This helps in identifying similar inventions and understanding how US 8,383,611 differentiates itself[1].

Global Dossier

The Global Dossier service allows users to see the patent family for a specific application, including related applications filed at participating IP Offices. This can provide insights into how the invention is protected globally[1].

International Patent Databases

Searching international patent databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO) can reveal similar patents filed in other countries[1].

Economic and Legal Implications

The economic and legal implications of a patent like US 8,383,611 are significant.

Market Impact

The patent protects a specific pharmaceutical composition, giving the assignee a competitive edge in the market. This can influence pricing, market share, and the development of similar products.

Legal Considerations

The patent's validity and enforceability are crucial. Any challenges or litigation related to this patent could have significant legal and financial implications. For instance, the concept of a small claims patent court, as studied by the Administrative Conference of the United States (ACUS), could potentially impact how disputes related to this patent are resolved[2].

Data and Statistics

Analyzing patent data can provide valuable insights into the scope and impact of a patent.

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset, which includes detailed information on claims from US patents, can be used to analyze the scope and trends of patent claims. This dataset can help in understanding how the claims of US 8,383,611 compare to other patents in the pharmaceutical sector[3].

Expert Insights

Industry experts and legal practitioners often provide valuable insights into the significance and implications of a patent.

"Patent claims are the lifeblood of any patent, as they define the scope of protection. Understanding these claims is crucial for both inventors and competitors," - Alan C. Marco, Former Chief Economist for the USPTO[3].

Conclusion

Understanding the scope and claims of United States Patent 8,383,611 involves a detailed analysis of its claims, the description of the invention, and the broader patent landscape. This patent protects a specific pharmaceutical composition and method of treatment, giving its assignee significant market and legal advantages.

Key Takeaways

  • Claims Analysis: The patent contains 31 claims, including independent and dependent claims that define the pharmaceutical composition and its use.
  • Scope of the Invention: The invention involves a pharmaceutical composition with ciclesonide and a cellulose-based polymer, designed for treating respiratory disorders.
  • Patent Landscape: Understanding related patents and global filings is crucial for navigating the intellectual property landscape.
  • Economic and Legal Implications: The patent has significant market and legal implications, influencing competition and potential litigation.
  • Data and Statistics: Analyzing patent data can provide insights into the scope and trends of patent claims.

FAQs

  1. What is the main subject of United States Patent 8,383,611?

    • The main subject is a pharmaceutical composition comprising ciclesonide and a cellulose-based polymer.
  2. How many claims does the patent have?

    • The patent has 31 claims.
  3. What is the significance of the Global Dossier service in patent searching?

    • The Global Dossier service allows users to see the patent family for a specific application, including related applications filed at participating IP Offices.
  4. How can one analyze the economic impact of a patent like US 8,383,611?

    • By examining market data, competition, and legal considerations, one can analyze the economic impact of the patent.
  5. What is the role of the Patent Claims Research Dataset in understanding patent scope?

    • The dataset provides detailed information on claims from US patents, helping to analyze the scope and trends of patent claims.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,383,611

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,383,611

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan11/298186Oct 20, 1999
PCT Information
PCT FiledOctober 20, 2000PCT Application Number:PCT/JP00/07351
PCT Publication Date:April 26, 2001PCT Publication Number: WO01/28563

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.